Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy.
暂无分享,去创建一个
C. Perno | M. Ciccozzi | G. Rezza | C. Perno | M. Santoro | A. Latini | G. Palamara | C. Alteri | M. Giuliani | S. Montieri
[1] F. Baldanti,et al. Changes in circulation of B and non‐B HIV strains: Spotlight on a reference centre for infectious diseases in Northern Italy , 2008, Journal of medical virology.
[2] Carlo Torti,et al. Updated prevalence of genotypic resistance among HIV‐1 positive patients naïve to antiretroviral therapy: a single center analysis , 2008, Journal of medical virology.
[3] S. Little,et al. Antiretroviral Drug Resistance and Risk Behavior Among Recently HIV-Infected Men Who Have Sex With Men , 2008, Journal of acquired immune deficiency syndromes.
[4] A. Nardone,et al. Continuing high levels of HIV diagnoses in men who have sex with men in the United Kingdom. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[5] M. Colafigli,et al. Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure. , 2008, AIDS research and human retroviruses.
[6] M. Debruyne,et al. The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in Portugal , 2008, Retrovirology.
[7] H. Xing,et al. Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China , 2007, AIDS.
[8] A. Nardone,et al. HIV/AIDS in Europe: epidemiological situation in 2006 and a new framework for surveillance. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[9] C. Mercer,et al. Sex partner acquisition while overseas: results from a British national probability survey , 2007, Sexually Transmitted Infections.
[10] H. R. Lacerda,et al. Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil. , 2007, Memorias do Instituto Oswaldo Cruz.
[11] Gkikas Magiorkinis,et al. Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin. , 2007, The Journal of infectious diseases.
[12] Jörg Schüpbach,et al. Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey , 2007, AIDS.
[13] S. B. Ferreira,et al. Human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns among treatment‐naive patients in different stages of infection in Rio de Janeiro, Brazil , 2007, Journal of medical virology.
[14] J. Desenclos,et al. Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France. , 2007, The Journal of infectious diseases.
[15] M. Chesney,et al. Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection , 2007, AIDS.
[16] M. Salemi,et al. An outbreak of HIV-1 subtype G among Italian injecting drug users , 2007, AIDS.
[17] F. Buonaguro,et al. Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example , 2007, Retrovirology.
[18] S. Dougan,et al. Sexually Transmitted Infections in Western Europe Among HIV-Positive Men Who Have Sex With Men , 2007, Sexually transmitted diseases.
[19] Ronald B Geskus,et al. HIV incidence and HIV testing behavior in men who have sex with men: using three incidence sources, The Netherlands, 1984–2005 , 2007, AIDS.
[20] J. Parry,et al. Human Immunodeficiency Virus (HIV) Antibody Avidity Testing To Identify Recent Infection in Newly Diagnosed HIV Type 1 (HIV-1)-Seropositive Persons Infected with Diverse HIV-1 Subtypes , 2006, Journal of Clinical Microbiology.
[21] M. Thomson,et al. Isolation and biological characterization of HIV‐1 BG intersubtype recombinants and other genetic forms circulating in Galicia, Spain , 2006, Journal of medical virology.
[22] M. Salminen,et al. HIV epidemiology in the Northwestern Federal District of Russia: dominance of HIV type 1 subtype A. , 2006, AIDS research and human retroviruses.
[23] M. Peeters,et al. Genetic and phylogenetic characterization of structural genes from non-B HIV-1 subtypes in Italy. , 2006, AIDS research and human retroviruses.
[24] J. Carr,et al. Genetic forms of HIV Type 1 in the former Soviet Union dominate the epidemic in Azerbaijan. , 2006, AIDS research and human retroviruses.
[25] A. Mocroft,et al. HIV-1 Subtypes and Response to Combination Antiretroviral Therapy in Europe , 2006, Antiviral therapy.
[26] J. Carr,et al. HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia. , 2006, AIDS research and human retroviruses.
[27] P. Easterbrook,et al. Evidence for Onward Transmission of HIV-1 Non-B Subtype Strains in the United Kingdom , 2006, Journal of acquired immune deficiency syndromes.
[28] Tulio de Oliveira,et al. An automated genotyping system for analysis of HIV-1 and other microbial sequences , 2005, Bioinform..
[29] Klaus Korn,et al. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. , 2005, The Journal of infectious diseases.
[30] A. Carlo,et al. Increased HIV incidence among men who have sex with men in Rome , 2005, AIDS.
[31] K. Ariyoshi,et al. Heterosexual transmission of novel CRF01_AE and subtype B recombinant forms of HIV type 1 in northern Thailand. , 2005, AIDS research and human retroviruses.
[32] F. Ceccherini‐Silberstein,et al. Molecular diversity of HIV in Albania. , 2005, The Journal of infectious diseases.
[33] F. Mazzotta,et al. HIV‐1 subtypes and circulating recombinant forms (CRFs) from HIV‐infected patients residing in two regions of central and southern Italy , 2005, Journal of medical virology.
[34] J. Desenclos,et al. Preliminary results from the new HIV surveillance system in France. , 2004, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[35] A. Lazzarin,et al. Screening of HIV-1 Isolates by Reverse Heteroduplex Mobility Assay and Identification of Non-B Subtypes in Italy , 2004, Journal of acquired immune deficiency syndromes.
[36] F. Ceccherini‐Silberstein,et al. Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure , 2004, AIDS.
[37] W. Heneine,et al. The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. , 2004, The Journal of infectious diseases.
[38] D. Goldberg,et al. HIV-1 subtype in Scotland: the establishment of a national surveillance system , 2004, Epidemiology and Infection.
[39] J. Hodgson,et al. A murine leukemia virus with Cre-LoxP excisible coding sequences allowing superinfection, transgene delivery, and generation of host genomic deletions , 2004, Retrovirology.
[40] Graham Bolding,et al. Web-Based Behavioral Surveillance Among Men Who Have Sex With Men: A Comparison of Online and Offline Samples in London, UK , 2004, Journal of acquired immune deficiency syndromes.
[41] M. Negishi,et al. Differential prevalence of HIV type 1 subtype B and CRF01_AE among different sexual transmission groups in Tokyo, Japan, as revealed by subtype-specific PCR. , 2003, AIDS research and human retroviruses.
[42] Huynh Tan Tien,et al. HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large predominance of CRF01_AE and presence of major resistance mutations to antiretroviral drugs. , 2003, AIDS research and human retroviruses.
[43] M. Robb,et al. Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Resistance Is Associated with the Syncytium-Inducing Phenotype and Lower CD4 Cell Counts in Subtype CRF01_AE-Infected Patients , 2003, Journal of Virology.
[44] Á. Holguín,et al. High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid , 2002, AIDS.
[45] P Pezzotti,et al. Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy. , 2001, The Journal of infectious diseases.
[46] M. Moroni,et al. Increasing Prevalence of Non‐Clade B HIV‐1 Strains in Heterosexual Men and Women, as Monitored by Analysis of Reverse Transcriptase and Protease Sequences , 2001, Journal of acquired immune deficiency syndromes.
[47] A. Vinattieri,et al. Detection of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy. , 2000, AIDS.
[48] F. Brun-Vézinet,et al. HIV-1 diversity in France, 1996–1998 , 2000 .
[49] M. Youle,et al. Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy. , 1999, AIDS.
[50] A. Phillips,et al. The prevalence of non-B subtype HIV-1 in a London HIV/AIDS outpatient clinic. , 1999, AIDS.
[51] David R. Holtgrave,et al. Cost‐effectiveness of post‐exposure prophylaxis following sexual exposure to HIV , 1998, AIDS.
[52] F. Brun-Vézinet,et al. HIV‐1 diversity in Romania , 1998, AIDS.
[53] J. Thompson,et al. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.
[54] M. Moroni,et al. Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals. , 1997, AIDS research and human retroviruses.
[55] M. Laga,et al. Longstanding presence in Belgians of multiple non-B HIV-1 subtypes , 1996, The Lancet.
[56] M. Uhlén,et al. Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden. , 1995, Virology.
[57] Huldrych F Günthard,et al. Update of the drug resistance mutations in HIV-1: Spring 2008. , 2008, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[58] O. Hamouda,et al. HIV incidence increasing in MSM in Germany: factors influencing infection dynamics. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[59] D. Swofford. PAUP*: Phylogenetic analysis using parsimony (*and other methods), Version 4.0b10 , 2002 .
[60] H. Fleury,et al. HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network. , 2000, AIDS.
[61] M. Zwahlen,et al. High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. , 1999, Journal of acquired immune deficiency syndromes.
[62] T. A. Hall,et al. BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT , 1999 .
[63] S. Ruță,et al. Dynamics of the HIV-1 variability in adults from Bucharest, 1992-1998. , 1999, Romanian journal of virology.
[64] M. Schwaber,et al. Outpatient clinic. , 1996, Annals of internal medicine.